Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

S A Hussain1, D R Ferry, G El-Gazzaz

  • 1CRC Institute for Cancer Studies, University Hospital Birmingham, Edgbaston, UK.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|April 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally. More rigorous clinical trials are needed to evaluate treatments for unresectable liver cancer and improve patient outcomes.

Area of Science:

  • Hepatology
  • Oncology
  • Clinical Trials

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer with high mortality.
  • Current treatment options for unresectable HCC are limited.
  • There is a need for evidence-based treatment strategies.

Purpose of the Study:

  • To review current therapeutic interventions for HCC not amenable to surgery.
  • To highlight the challenges in evaluating treatment efficacy.
  • To emphasize the need for multicenter controlled trials.

Main Methods:

  • Review of existing therapeutic interventions for unresectable HCC.
  • Discussion of limitations in current research, including a lack of powered randomized clinical trials.
  • Identification of future research priorities.

Related Experiment Videos

Main Results:

  • Surgical resection and liver transplantation are preferred for select HCC cases.
  • Investigated treatments include ablation, chemoembolization, and systemic chemotherapy.
  • Efficacy evaluation is hindered by insufficient clinical trial data.

Conclusions:

  • Prioritizing promising treatments for multicenter controlled trials is crucial.
  • Standardizing treatment evaluation will reduce clinical practice variation.
  • Advancing research is essential to improve outcomes for liver cancer patients.